Corticostriatal Beta Power Changes Associated with Cognitive Function in Parkinson’s Disease

Autor: DL Paulo, H Qian, D Subramanian, GW Johnson, K Hett, C Kao, N Roy, K Dhima, DO Claassen, SK Bick

Cognitive impairment (CI) is the most frequent nonmotor symptom in Parkinson’s Disease (PD) and is associated with deficits in executive functions such as working memory. Previous studies have demonstrated that caudate beta power is involved in lea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3da181e1632c9411b44e23786b98ca3e
https://doi.org/10.1101/2022.07.07.499165

Apathy and Functional Status in Early-Stage Huntington's Disease.

Autor: Gibson JS; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., Hay KR; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., Claassen DO; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., McDonell KE; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., Brown AE; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., Wynn A; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., Jiang J; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs)., Isaacs DA; University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs).

Publikováno v: The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 2024 Nov 19, pp. appineuropsych20230225. Date of Electronic Publication: 2024 Nov 19.

Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments: A Decision-Modeling Analysis.

Autor: Guzauskas GF; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Tabrizi SJ; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Long JD; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Arnesen A; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Hamilton JL; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Claassen DO; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Munetsi LR; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Malik S; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Rodríguez-Santana I; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Ali TM; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA., Zhang F; The Comparative Health Outcomes (GFG), Policy, and Economics Institute, Department of Pharmacy, University of Washington, Seattle, WA and HCD Economics, Daresbury; Huntington's Disease Centre (GFG, LRM, SM, IRS), UCL Queen Square Institute of Neurology, London, United Kingdom; The University of Iowa Health Care (SJT), Iowa City, IA; European Huntington Association (JDL), Moerbeke Waas, Belgium; Clinical Department (AA), CHDI Management/CHDI Foundation, Princeton, NJ; Department of Neurology (JLH), Vanderbilt University Medical Center, Nashville, TN; HCD Economics (DOC), Daresbury, United Kingdom; and uniQure Inc. (TMA, FZ), Lexington, MA.

Publikováno v: Neurology. Clinical practice [Neurol Clin Pract] 2024 Oct; Vol. 14 (5), pp. e200340. Date of Electronic Publication: 2024 Aug 15.

Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.

Autor: Frank S; Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA, 02215, USA. sfrank2@bidmc.harvard.edu., Anderson KE; Georgetown University, Washington, DC, USA., Fernandez HH; Cleveland Clinic, Cleveland, OH, USA., Hauser RA; University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, FL, USA., Claassen DO; Vanderbilt University Medical Center, Nashville, TN, USA., Stamler D; Teva Branded Pharmaceutical Products R&D, Inc., La Jolla, CA, USA., Factor SA; Emory University, Atlanta, GA, USA., Jimenez-Shahed J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Barkay H; Teva Pharmaceutical Industries Ltd., Netanya, Israel., Wilhelm A; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Alexander JK; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Chaijale N; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Barash S; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Savola JM; Teva Pharmaceuticals International GmbH, Basel, Switzerland., Gordon MF; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Chen M; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.

Publikováno v: Neurology and therapy [Neurol Ther] 2024 Jun; Vol. 13 (3), pp. 655-675. Date of Electronic Publication: 2024 Apr 01.

Reduced cerebrospinal fluid motion in patients with Parkinson's disease revealed by magnetic resonance imaging with low b-value diffusion weighted imaging.

Autor: Pierobon Mays G; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Hett K; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Eisma J; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., McKnight CD; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Elenberger J; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Song AK; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Considine C; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Richerson WT; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Han C; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Stark A; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Claassen DO; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Donahue MJ; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA. mj.donahue@vumc.org.; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. mj.donahue@vumc.org.

Publikováno v: Fluids and barriers of the CNS [Fluids Barriers CNS] 2024 May 09; Vol. 21 (1), pp. 40. Date of Electronic Publication: 2024 May 09.